Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP
Bone Marrow Transplantation, Published online: 16 April 2024; doi:10.1038/s41409-024-02286-3Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 16, 2024 Category: Hematology Authors: Jacek Wachowiak Jacques-Emmanuel Galimard Arnaud Dalissier Rawad Rihani Hawazen AlSaedi Robert F. Wynn Jean-Hugues Dalle R égis Peffault de Latour Petr Sedlacek Adriana Balduzzi Thomas Schroeder Ivana Bodova Marta Gonzalez Vicent Bernd Gruhn Rose-Marie H Source Type: research

Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity
Bone Marrow Transplantation, Published online: 16 April 2024; doi:10.1038/s41409-024-02278-3Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 16, 2024 Category: Hematology Authors: Emily C. Liang Kai Rejeski Teng Fei Aya Albittar Jennifer J. Huang Andrew J. Portuguese Qian Wu Sandeep Raj Marion Subklewe Roni Shouval Jordan Gauthier Source Type: research

Herpes simplex virus reactivation among hematopoietic stem cell transplant recipients: re-evaluating acyclovir dosage
Bone Marrow Transplantation, Published online: 16 April 2024; doi:10.1038/s41409-024-02273-8Herpes simplex virus reactivation among hematopoietic stem cell transplant recipients: re-evaluating acyclovir dosage (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 16, 2024 Category: Hematology Authors: Nada Alsuhebany Bashayer Alshehri Atheer Aldairem Muneerah M. Aleissa Hajar AlQahtani Khalid Albarqi Basil Almotairi Mohammed AlAmri Walid Alanazi Saeed Alay Bader Alahmari Mohsen Alzahrani Source Type: research

AI in wine and haematology
Bone Marrow Transplantation, Published online: 16 April 2024; doi:10.1038/s41409-024-02285-4AI in wine and haematology (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 16, 2024 Category: Hematology Authors: Shaun R. McCann Source Type: research

Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Published online: 13 April 2024; doi:10.1038/s41409-024-02284-5Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 13, 2024 Category: Hematology Authors: Arnon Nagler Myriam Labopin Ryszard Swoboda Thomas Schroeder Rose-Marie Hamladji Laimonas Griskevicius Urpu Salmenniemi Alessandro Rambaldi Stephan Mielke Alexander Kulagin Jakob Passweg Thomas Luft Tobias Gedde-Dahl Edouard Forcade Grzegorz Helbig Matthi Source Type: research

Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil
Bone Marrow Transplantation, Published online: 13 April 2024; doi:10.1038/s41409-024-02283-6Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 13, 2024 Category: Hematology Authors: Camila D. Donadel Gil C. De Santis Thiago E. Gon çalves Bruno G. Pires Leonardo C. Palma Flavia Gava Renato Luiz Guerino-Cunha Joana T. B. Faria Gabriela V. A. Silva Luiz Guilherme Darrigo-Junior Giancarlo Fatobene Vanderson Rocha Dimas T. Covas Rodrigo Source Type: research

Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score matching-based study
Bone Marrow Transplantation, Published online: 13 April 2024; doi:10.1038/s41409-024-02280-9Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score matching-based study (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 13, 2024 Category: Hematology Authors: Yifan Shen Minyuan Liu Danya Shen Mengqian Chu Xuekai Li Xiang Zhang Yi Fan Jia Chen Depei Wu Shaoyan Hu Yang Xu Source Type: research

Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT
Bone Marrow Transplantation, Published online: 11 April 2024; doi:10.1038/s41409-024-02279-2Efficacy of eculizumab in transplantation-associated thrombotic microangiopathy: results of the French nationwide study on behalf of the SFGM-TC and the CNR-MAT (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 11, 2024 Category: Hematology Authors: Marion Peyre Flore Sicre de Fontbrune Ana Berceanu Lise Benjemia Martin Castelle Maud D ’Aveni Ambroise Mar çais Eleonore Kaphan Claude-Eric Bulabois Anne Sirvent Pierre-Simon Rohrlich Valerie Coiteux Sylvain Chantepie St éphanie Nguyen-Quoc R égis P Source Type: research

Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning
Bone Marrow Transplantation, Published online: 10 April 2024; doi:10.1038/s41409-024-02277-4Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 10, 2024 Category: Hematology Authors: Lining Wang Guilin Xu Ling Wang Jieling Jiang Wenhui Gao Ming Wan Didier Blaise Jiong Hu Source Type: research

Insulin eye drops for severe refractory chronic ocular graft-versus-host disease
Bone Marrow Transplantation, Published online: 10 April 2024; doi:10.1038/s41409-024-02272-9Insulin eye drops for severe refractory chronic ocular graft-versus-host disease (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 10, 2024 Category: Hematology Authors: V. Tahmaz L. Menghesha M. E. Stern U. Holtick C. Scheid P. Steven Source Type: research

Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience
Bone Marrow Transplantation, Published online: 09 April 2024; doi:10.1038/s41409-024-02281-8Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 9, 2024 Category: Hematology Authors: Dimitrios Filioglou Laurel Truscott Naresh Reddivalla Emmanuel Katsanis Source Type: research

Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients
Bone Marrow Transplantation, Published online: 05 April 2024; doi:10.1038/s41409-024-02266-7Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 5, 2024 Category: Hematology Authors: Xiaoyu Zhang Xiaoli Zhao Shulian Chen Mengze Hao Lining Zhang Ming Gong Yuanyuan Shi Jialin Wei Ping Zhang Sizhou Feng Yi He Erlie Jiang Mingzhe Han Source Type: research

Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience
Bone Marrow Transplantation, Published online: 02 April 2024; doi:10.1038/s41409-024-02276-5Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - April 2, 2024 Category: Hematology Authors: Rui Ma Dan-Ping Zhu Xiao-Hui Zhang Lan-Ping Xu Yu Wang Xiao-Dong Mo Meng Lv Yuan-Yuan Zhang Yi-Fei Cheng Chen-Hua Yan Yu-Hong Chen Yao Chen Jing-Zhi Wang Feng-Rong Wang Ting-Ting Han Jun Kong Zhi-Dong Wang Wei Han Huan Chen Ying-Jun Chang Yun He Zheng-Li Source Type: research

Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplantation, Published online: 30 March 2024; doi:10.1038/s41409-024-02275-6Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - March 30, 2024 Category: Hematology Authors: Enrico Maffini Myriam Labopin Nicolaus Kr öger J ürgen Finke Matthias Stelljes Thomas Schroeder Herman Einsele Johanna Tischer Martin Bornh äuser Wolfgang Bethge Arne Brecht Wolf R ösler Peter Dreger Kerstin Sch äfer-Eckart Jakob Passweg Igor Wolfgan Source Type: research

A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome
Bone Marrow Transplantation, Published online: 27 March 2024; doi:10.1038/s41409-023-02195-xA phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - March 27, 2024 Category: Hematology Authors: Ray Mun Koo Eric Wong Joanne E. Davis Travis Perera Andrew Lim Rachel M. Koldej David S. Ritchie Source Type: research